Review and perspectives on pharmacological vitreolysis

Francesco Bandello; Carlo La Spina; Lorenzo Iuliano; Giovanni Fogliato; Maurizio Battaglia Parodi

doi:10.1159/000354547

Review and perspectives on pharmacological vitreolysis

Francesco Bandello, Carlo La Spina, Lorenzo Iuliano, Giovanni Fogliato, Maurizio Battaglia Parodi

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

The vitreous is involved in multiple diseases when an incomplete posterior vitreous detachment (PVD) occurs. An incomplete PVD can lead to several pathological conditions. Such visually threatening conditions are traditionally of exclusive surgical interest. In contrast, pharmacological vitreolysis is the effort to reduce or eliminate the pathogenetic role of the vitreous solely by means of drug delivery. Here we aim to review and summarize the evidence available to date about this challenging new approach.

Original language	English
Pages (from-to)	179-185
Number of pages	7
Journal	Ophthalmologica
Volume	230
Issue number	4
DOIs	https://doi.org/10.1159/000354547
Publication status	Published - Nov 2013

Keywords

Ocriplasmin
Plasmin
Vitreolysis

ASJC Scopus subject areas

Ophthalmology
Sensory Systems

Access to Document

10.1159/000354547

Fingerprint Dive into the research topics of 'Review and perspectives on pharmacological vitreolysis'. Together they form a unique fingerprint.

Cite this

@article{dce24a6a14244fd08f3bbf5e4e32a72b,

title = "Review and perspectives on pharmacological vitreolysis",

abstract = "The vitreous is involved in multiple diseases when an incomplete posterior vitreous detachment (PVD) occurs. An incomplete PVD can lead to several pathological conditions. Such visually threatening conditions are traditionally of exclusive surgical interest. In contrast, pharmacological vitreolysis is the effort to reduce or eliminate the pathogenetic role of the vitreous solely by means of drug delivery. Here we aim to review and summarize the evidence available to date about this challenging new approach.",

keywords = "Ocriplasmin, Plasmin, Vitreolysis",

author = "Francesco Bandello and {La Spina}, Carlo and Lorenzo Iuliano and Giovanni Fogliato and Parodi, {Maurizio Battaglia}",

year = "2013",

month = nov,

doi = "10.1159/000354547",

language = "English",

volume = "230",

pages = "179--185",

journal = "Ophthalmologica",

issn = "0030-3755",

publisher = "S. Karger AG",

number = "4",

}

TY - JOUR

T1 - Review and perspectives on pharmacological vitreolysis

AU - Bandello, Francesco

AU - La Spina, Carlo

AU - Iuliano, Lorenzo

AU - Fogliato, Giovanni

AU - Parodi, Maurizio Battaglia

PY - 2013/11

Y1 - 2013/11

N2 - The vitreous is involved in multiple diseases when an incomplete posterior vitreous detachment (PVD) occurs. An incomplete PVD can lead to several pathological conditions. Such visually threatening conditions are traditionally of exclusive surgical interest. In contrast, pharmacological vitreolysis is the effort to reduce or eliminate the pathogenetic role of the vitreous solely by means of drug delivery. Here we aim to review and summarize the evidence available to date about this challenging new approach.

AB - The vitreous is involved in multiple diseases when an incomplete posterior vitreous detachment (PVD) occurs. An incomplete PVD can lead to several pathological conditions. Such visually threatening conditions are traditionally of exclusive surgical interest. In contrast, pharmacological vitreolysis is the effort to reduce or eliminate the pathogenetic role of the vitreous solely by means of drug delivery. Here we aim to review and summarize the evidence available to date about this challenging new approach.

KW - Ocriplasmin

KW - Plasmin

KW - Vitreolysis

UR - http://www.scopus.com/inward/record.url?scp=84888247745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888247745&partnerID=8YFLogxK

U2 - 10.1159/000354547

DO - 10.1159/000354547

M3 - Article

C2 - 24029751

AN - SCOPUS:84888247745

VL - 230

SP - 179

EP - 185

JO - Ophthalmologica

JF - Ophthalmologica

SN - 0030-3755

IS - 4

ER -